Answer
No. Abrupt withdrawal can trigger rebound or worsening seizures; discontinuation should be planned and gradual under specialist supervision.
Sources for this answer
- Vigabatrin Zydus Pharmaceuticals UK 100 mg/ml Oral Solution — Current selected SmPCemc · Summary of Product Characteristics
- Sabril 500 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
- Kigabeq (vigabatrin) 100mg — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.